Side by side

Calocurb (Amarasate) vs MEDVi Weight Loss

The published reviews of Calocurb (Amarasate) and MEDVi Weight Loss, lined up: the five scores, what one serving delivers against the studied dose, the real cost per serving and what each label leaves out. Figures as of 25 September 2026.

The short answer

Calocurb (Amarasate) scores 6.6/10 against MEDVi Weight Loss's 4.2. The widest gap is label transparency: 8 for Calocurb (Amarasate), 3 for MEDVi Weight Loss.

Pick Calocurb (Amarasate) if…

  • you want every amount on the label disclosed
  • you want a serving that matches the amount used in research
  • you want the stronger evidence behind what it is sold to do

Pick MEDVi Weight Loss if…

  • you want better value against the plain generic version

Criterion by criterion

The five criteria every review is scored on, published on the grading page. The overall score is their average.

Evidence for the marketed claim

How strong the research is for what the product is actually sold to do — not for the ingredient in general.

Calocurb (Amarasate)7/10Leads
MEDVi Weight Loss5/10

Dose against the studied amount

Whether one serving delivers the amount used in the research behind the claim.

Calocurb (Amarasate)9/10Leads
MEDVi Weight Loss5/10

Label transparency

Whether the Supplement Facts panel is published in readable text and every active amount is disclosed.

Calocurb (Amarasate)8/10Leads
MEDVi Weight Loss3/10

Value against the generic equivalent

Cost per gram or per dose of the active ingredient, compared with the plainest version of the same thing.

Calocurb (Amarasate)3/10
MEDVi Weight Loss4/10Leads

Safety and tolerability

Known risks and interactions, how well characterised they are, and whether the label warns about them.

Calocurb (Amarasate)6/10Leads
MEDVi Weight Loss4/10

Dose against the studied amount

What one labelled serving delivers, placed against the range on each ingredient’s evidence page. Where a label gives no figure, there is nothing to place, and that is the finding.

Omega-3 (EPA and DHA)Evidence B

No single studied range in label units, so amounts are shown but not placed.

  • Calocurb (Amarasate)Not in the formula
  • MEDVi Weight LossWeekly injection; no price shown on the pages we read; 2.5 mg weekly, stepped up to 5–15 mg (label)

What it actually costs

Price divided by labelled servings, from a dated listing. A serving is whatever the label calls one, which is why the studied-dose row matters more than the headline figure.

  • Calocurb (Amarasate)$2.00 a serving · $89.99 for 45 servings at Amazon, checked 23 Sept 2026
  • MEDVi Weight Loss$149 first month, then $299 a month for compounded semaglutide (25 Sept 2026). No per-serving figure: servings not recorded.

Label checks

What each label discloses, and what it leaves out. Read from the reviews, not from the marketing.

Calocurb (Amarasate)

  • Every active ingredient has a stated amount
  • No third-party certification

MEDVi Weight Loss

  • Every active ingredient has a stated amount
  • No third-party certification

How this comparison is built

  • Scores are the ones already published in each review. Nothing is re-scored for the comparison, and a product leads a criterion only when it outscores the rest.
  • Doses are read from the label rows in each review and placed against the studied range on the matching ingredient page. A figure that is not printed is never estimated.
  • Costs use a dated retailer price divided by labelled servings. Prices in different currencies are never ranked against each other.
  • Only products in the same category, or ones a review names as an alternative, can be compared. Commission never changes what appears here.

Other comparisons